The potential of proteasome inhibitors in cancer therapy

Author: Sterz Jan   Metzler Ivana von   Hahne Jens-Claus   Lamottke Britta   Rademacher Jessica   Heider Ulrike   Terpos Evangelos   Sezer Orhan  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.17, Iss.6, 2008-06, pp. : 879-895

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract